- TRADE NAME: ReoPro (Janssen Biotech)
- INDICATIONS: Thrombotic arterial disease
- SYNONYM: C7E3
- CLASS: Antiplatelet (antithrombotic), Glycoprotein IIb/IIIa inhibitor, Monoclonal antibody
- HALF-LIFE: 10–30 minutes – given intravenously
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Anticoagulants, Antiplatelets, Collagenase, Dasatinib, Dextran, Drotrecogin Alfa, Fondaparinux, Glucosamine, Herbals with anticoagulant properties, Lepirudin, Monoclonal antibodies, NSAIDs, Omega-3 Fatty Acids, Pentosan, Pentoxifylline, Prostacyclin analogues, Reteplase, Salicylates, Thrombolytic agents, Tositumomab & Iodine131, Trastuzumab
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
